Catalyst Biosciences, Inc. Profile Avatar - Palmy Investing

Catalyst Biosciences, Inc.

Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecul…

Biotechnology
US, South San Francisco [HQ]
Strategy & Leadership

Mergers & Acquisitions Beta

M&A Deals · Breakdown

Catalyst Biosciences, Inc. has no acquisition track records yet.

M&A Deals · History

Catalyst Biosciences, Inc. has no acquisition track records yet.

End of CBIO's Analysis
CIK: 1124105 CUSIP: 14888D208 ISIN: US4037831033 LEI: - UEI: -
Secondary Listings
CBIO has no secondary listings inside our databases.